Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Clin Med ; 11(4)2022 Feb 10.
Article in English | MEDLINE | ID: mdl-35207193

ABSTRACT

Neuroendocrine neoplasms (NENs) constitute a heterogenous group of tumors originating from neuroendocrine cells scattered throughout the body. Peptide Receptor Radionuclide Therapy (PRRT) is a treatment of choice of unresectable metastasized progressive and well-differentiated NENs. The aim of the study was to assess early bone marrow and kidney injury after administration of Lutetium-177 or Lutetium-177 combined with Yttrium-90. Thirty-one patients received treatment with [177Lu]Lu-DOTATATE with the activity of 7.4 GBq. Eleven patients received tandem treatment with [90Y]Y-DOTATATE with the activity of 1.85 GBq + [177Lu]Lu-DOTATATE with the activity of 1.85 GBq. After PRRT a significant decrease in leukocyte, neutrophil, and lymphocyte counts was noted. Tandem treatment demonstrated a more marked decrease in white blood cell count compared to Lutetium-177 therapy only. Conversely, no significant influence on glomerular filtration was found in this assessment. However, PRRT triggered acute renal tubule dysfunction, regardless of the treatment type. Regarding the acute complications, PRRT appeared to be a safe modality in the treatment of patients with NEN.

2.
Pneumonol Alergol Pol ; 82(6): 495-502, 2014.
Article in English | MEDLINE | ID: mdl-25339559

ABSTRACT

INTRODUCTION: Non-tuberculous mycobacterial lung diseases (NTMLD) occur rarely and are diagnosed mainly in patients belonging to risk groups. Pulmonary hypertension (PH) has not been recognised as a risk factor for NTMLD yet. The aim of the study was to analyse the clinical course and predisposing factors of NTMLD recognised in our centre between 2002 and 2012 in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH). MATERIAL AND METHODS: Thirteen patients (10 - CTEPH, 3 - IPAH) entered the study. PH was recognised during right heart catheterisation. Median value of mean pulmonary artery pressure (mPAP) was 49 mm Hg (39-65 mm Hg). NTMLD was diagnosed according to ATS guidelines (2007). RESULTS: M. kansasii was the most frequent pathogen. Most patients complained of the exaggeration of dyspnoea and productive cough. Computed tomography of the chest with angiography revealed infiltrations with cavitation in seven patients and cavities surrounded by micronodules in six patients. In all CTEPH patients, NTMLD developed in the hypoperfused lung areas. No parenchymal abnormalities preceded the development of NTMLD. After diagnosis all of the patients received antituberculous treatment; in 12/13 improvement was achieved. By the end of March 2014 seven patients died due to right heart insufficiency, no deaths due to NTMLD were noted. CONCLUSIONS: NTMLD should be suspected in patients with CTEPH or IPAH, presenting with productive cough and a new pulmonary infiltrate with cavitation. In patients with CTEPH, special attention should be paid to a new cavitary lesions without accompanying thrombus in the artery supplying the area. High mPAP (CTEPH/IPAH) and hypoperfusion (CTEPH) are predisposing to NTMLD.


Subject(s)
Familial Primary Pulmonary Hypertension/microbiology , Hypertension, Pulmonary/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Pulmonary Embolism/microbiology , Familial Primary Pulmonary Hypertension/complications , Familial Primary Pulmonary Hypertension/diagnosis , Female , Humans , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/drug therapy , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium Infections, Nontuberculous/drug therapy , Nontuberculous Mycobacteria/isolation & purification , Pulmonary Embolism/complications , Pulmonary Embolism/diagnosis
3.
Pneumonol Alergol Pol ; 79(3): 215-21, 2011.
Article in Polish | MEDLINE | ID: mdl-21509734

ABSTRACT

Pericardial effusion is caused by various pathological agents. In differential diagnosis infectious as well as non-infectious factors have to be considered. Adult-onset Still disease (AOSD)--relatively uncommon systemic inflammatory disorder of unknown etiology--is among possible diagnosis. The disease typically affects patients in the age between 16-35 years and is characterized by spiking fever, arthralgia, evanescent salmon rash with other abnormalities including pharingitis, serositis (especially pleuritis and pericarditis) and leucocytosis as well as increased serum levels of inflammatory indicators. We present two patients with recurrent pericardial effusion in the course of AOSD.


Subject(s)
Pericardial Effusion/etiology , Pericarditis/complications , Pericarditis/diagnosis , Still's Disease, Adult-Onset/complications , Still's Disease, Adult-Onset/diagnosis , Adolescent , Adult , Diagnosis, Differential , Humans , Male , Recurrence
4.
Pneumonol Alergol Pol ; 78(6): 445-50, 2010.
Article in English | MEDLINE | ID: mdl-21077037

ABSTRACT

Primary Sjögren's Syndrome (pSS) is a chronic, slowly progressive inflammatory autoimmune disorder, characterised by lymphocytic infiltration of the exocrine glands, leading to decrease of glandular secretion. In 40-60% of pSS patients, extraglandular disease develops. We present the case of a patient with two extraglandular sites involvement in the course of pSS manifesting with progressive respiratory and gastrointestinal symptoms.


Subject(s)
Abdominal Pain/etiology , Hypertension, Pulmonary/etiology , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/drug therapy , Abdominal Pain/drug therapy , Aged , Female , Glucocorticoids/administration & dosage , Humans , Hypertension, Pulmonary/drug therapy , Prednisone/administration & dosage , Radiography , Sjogren's Syndrome/complications , Sjogren's Syndrome/diagnostic imaging , Sjogren's Syndrome/pathology , Treatment Outcome
5.
Pneumonol Alergol Pol ; 78(2): 138-47, 2010.
Article in Polish | MEDLINE | ID: mdl-20306426

ABSTRACT

Nontuberculous mycobacteria (NTM) are a group of bacteria that may cause human disease mycobacteriosis, but do not cause tuberculosis or leprosy. NTM are acquired through environmental exposure to water, aerosols, soil, dust and are transferred to humans through inhalation, ingestion, and skin lesions, due to injuries, surgical procedures, or intravenous catheters. People with suppressed immune response, with pre-existing lung damage in the course of various lung diseases are most likely to be affected. There is no evidence of person-to-person spread of these diseases. A variety of manifestations of NTM infection have been described, but the lungs remain the most commonly involved site. Molecular methods allow the quicker differentiation of NTM from TB isolates and help to identify new NTM species. The purpose of this article is to review the common clinical manifestations of NTM lung disease, the conditions associated with NTM lung disease, diagnostic criteria and treatment of the most frequent species of NTM.


Subject(s)
Lung Diseases/diagnosis , Lung Diseases/therapy , Mycobacterium Infections/diagnosis , Mycobacterium Infections/therapy , Mycobacterium/classification , Mycobacterium/isolation & purification , Anti-Infective Agents/therapeutic use , Humans , Lung Diseases/microbiology , Mycobacterium Infections/microbiology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...